Relay Therapeutics News

This is selected news for Relay Therapeutics, which is filed under Sectors / Healthtech. There are 1.1K news items for this page. Relay Therapeutics is occasionally combined with Sanjiv Patel, EcoR1 Capital and Brian Adams in news items.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
9/25/2022 Scholar Rock (NASDAQ:SRRK) vs. Relay Therapeutics (NASDAQ:RLAY) Critical Survey
Scholar Rock (NASDAQ:SRRK ‚Ai Get Rating) and Relay Therapeutics (NASDAQ:RLAY ‚Ai Get Rating) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, risk, valuation, earnings and dividends. Risk & Volatility Scholar ...
etfdailynews.com
9/25/2022 Comparing Relay Therapeutics (NASDAQ:RLAY) and Scholar Rock (NASDAQ:SRRK)
Relay Therapeutics (NASDAQ:RLAY ‚Ai Get Rating) and Scholar Rock (NASDAQ:SRRK ‚Ai Get Rating) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, dividends and earnings. Earnings & Valuation This ...
defenseworld.net
9/23/2022 Head to Head Analysis: Scholar Rock (NASDAQ:SRRK) versus Relay Therapeutics (NASDAQ:RLAY) - The Cerbat Gem
Relay Therapeutics ( NASDAQ:RLAY ‚Ai Get Rating ) and Scholar Rock ( NASDAQ:SRRK ‚Ai Get Rating ) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, valuation, risk, analyst recommendations and earnings. Profitability This table ...
thecerbatgem.com
9/23/2022 7 Unknown Biotech Stocks That Could Rocket in 2023
... look at the reasons that make these unknown biotech stocks interesting. NKTX Nkarta $12.40 IBRX ImmunityBio $4.96 FGEN FibroGen $12.09 HRTX Heron Therapeutics $4.26 RNA Avidity Biosciences $20.01 SANA Sana Biotechnologies $6.22 RLAY Relay Therapeutics $22.08 Nkarta Nkarta (NASDAQ:NKTX) stock has been trending lower in the last 12 months ...
investorplace.com
9/22/2022 Head to Head Analysis: Scholar Rock (NASDAQ:SRRK) versus Relay Therapeutics (NASDAQ:RLAY)
Relay Therapeutics ( NASDAQ:RLAY ‚Ai Get Rating ) and Scholar Rock ( NASDAQ:SRRK ‚Ai Get Rating ) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, valuation, risk, analyst recommendations and earnings. This table compares ...
Daily Political
9/21/2022 Relay Therapeutics, Inc. (NASDAQ:RLAY) Given Consensus Rating of “Moderate Buy” by Brokerages - Transcript Daily transcriptdaily.com
9/21/2022 Relay Therapeutics, Inc. (NASDAQ:RLAY) Given Consensus Rating of “Moderate Buy” by Brokerages com-unik.info
9/21/2022 Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives Average Recommendation of “Moderate Buy” from Brokerages theenterpriseleader.com
9/20/2022 Head-To-Head Survey: Relay Therapeutics (NASDAQ:RLAY) and Anavex Life Sciences (NASDAQ:AVXL) - WKRB News wkrb13.com
9/19/2022 Analysts Set Relay Therapeutics, Inc. (NASDAQ:RLAY) Price Target at $40.13 - Watch List News watchlistnews.com
9/19/2022 Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives Average Rating of “Moderate Buy” from Analysts zolmax.com
9/19/2022 Analysts Set Relay Therapeutics, Inc. (NASDAQ:RLAY) Price Target at $40.13 thelincolnianonline.com
9/18/2022 Relay Therapeutics: Bile Duct Cancer Approval Shot Validates Pricey Platform Seeking Alpha
9/18/2022 Head-To-Head Contrast: Relay Therapeutics (NASDAQ:RLAY) & Anavex Life Sciences (NASDAQ:AVXL) - Ticker Report Ticker Report
9/18/2022 Reviewing Anavex Life Sciences (NASDAQ:AVXL) & Relay Therapeutics (NASDAQ:RLAY) zolmax.com
9/18/2022 Reviewing Anavex Life Sciences (NASDAQ:AVXL) & Relay Therapeutics (NASDAQ:RLAY) baseballnewssource.com
9/18/2022 Relay Therapeutics (NASDAQ:RLAY) PT Raised to $38.00 at JMP Securities - The Cerbat Gem thecerbatgem.com
9/18/2022 Relay Therapeutics (NASDAQ:RLAY) PT Raised to $38.00 at JMP Securities rivertonroll.com
9/18/2022 Relay Therapeutics (NASDAQ:RLAY) PT Raised to $38.00 at JMP Securities slatersentinel.com
9/18/2022 Insider Selling: Relay Therapeutics, Inc. (NASDAQ:RLAY) CEO Sells $328,580.00 in Stock - Ticker Report Ticker Report
9/17/2022 Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives $40.13 Consensus Price Target from Brokerages - Ticker Report Ticker Report
9/17/2022 Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives $40.13 Consensus Price Target from Brokerages baseballnewssource.com
9/17/2022 Relay Therapeutics (NASDAQ:RLAY) Stock Price Up 3.6% Following Analyst Upgrade zolmax.com
9/17/2022 JMP Securities Raises Relay Therapeutics (NASDAQ:RLAY) Price Target to $38.00 baseballnewssource.com
9/17/2022 Relay Therapeutics (NASDAQ:RLAY) Shares Up 3.6% on Analyst Upgrade baseballnewssource.com